- Home
- SKIL vs OBIO Comparison
SKIL vs OBIO Comparison
Compare SKIL & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKIL
- OBIO
- Stock Information
- Founded
- SKIL 1998
- OBIO 2017
- Country
- SKIL United States
- OBIO United States
- Employees
- SKIL N/A
- OBIO N/A
- Industry
- SKIL Computer Software: Prepackaged Software
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- SKIL Technology
- OBIO Health Care
- Exchange
- SKIL Nasdaq
- OBIO Nasdaq
- Market Cap
- SKIL 123.2M
- OBIO 146.2M
- IPO Year
- SKIL N/A
- OBIO N/A
- Fundamental
- Price
- SKIL $15.35
- OBIO $2.77
- Analyst Decision
- SKIL
- OBIO Strong Buy
- Analyst Count
- SKIL 0
- OBIO 4
- Target Price
- SKIL N/A
- OBIO $14.00
- AVG Volume (30 Days)
- SKIL 60.1K
- OBIO 224.0K
- Earning Date
- SKIL 09-09-2025
- OBIO 11-11-2025
- Dividend Yield
- SKIL N/A
- OBIO N/A
- EPS Growth
- SKIL N/A
- OBIO N/A
- EPS
- SKIL N/A
- OBIO N/A
- Revenue
- SKIL $524,001,000.00
- OBIO $2,944,000.00
- Revenue This Year
- SKIL $3.18
- OBIO $29.26
- Revenue Next Year
- SKIL $2.50
- OBIO $10.65
- P/E Ratio
- SKIL N/A
- OBIO N/A
- Revenue Growth
- SKIL N/A
- OBIO 41.61
- 52 Week Low
- SKIL $12.22
- OBIO $2.20
- 52 Week High
- SKIL $34.43
- OBIO $6.50
- Technical
- Relative Strength Index (RSI)
- SKIL 60.55
- OBIO 61.42
- Support Level
- SKIL $12.80
- OBIO $2.20
- Resistance Level
- SKIL $13.62
- OBIO $2.89
- Average True Range (ATR)
- SKIL 0.96
- OBIO 0.14
- MACD
- SKIL 0.17
- OBIO 0.04
- Stochastic Oscillator
- SKIL 87.93
- OBIO 82.61
About SKIL Skillsoft Corp.
Skillsoft Corp is a leader in corporate digital learning. The company's segment includes Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experience learner platform that serves learners world-wide. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.